Blood Disorder News and Research

RSS
Zebrafish provides insight into human melanoma

Zebrafish provides insight into human melanoma

U.S. to launch graphic anti-smoking warnings

U.S. to launch graphic anti-smoking warnings

HemaQuest closes $13 million extension of Series B financing

HemaQuest closes $13 million extension of Series B financing

Octapharma submits octaplasLG BLA with FDA to treat TTP

Octapharma submits octaplasLG BLA with FDA to treat TTP

National Library of Medicine acquires papers of sickle cell disease expert

National Library of Medicine acquires papers of sickle cell disease expert

Change in sickle cell anemia prevention strategies decreases racial disparities in stroke-related deaths

Change in sickle cell anemia prevention strategies decreases racial disparities in stroke-related deaths

Gene therapy can reduce painful bleeding episodes in patients with hemophilia B

Gene therapy can reduce painful bleeding episodes in patients with hemophilia B

FDA approves changes to REMS for Nplate and Promacta

FDA approves changes to REMS for Nplate and Promacta

EC extends therapeutic indication for Soliris to treat atypical hemolytic uremic syndrome

EC extends therapeutic indication for Soliris to treat atypical hemolytic uremic syndrome

Almac collaborates with Alexion for packaging and distribution of Soliris during German E. coli outbreak

Almac collaborates with Alexion for packaging and distribution of Soliris during German E. coli outbreak

Researchers discover new class of antimalarial compounds

Researchers discover new class of antimalarial compounds

Researchers to begin drug development projects for rare and neglected diseases

Researchers to begin drug development projects for rare and neglected diseases

Public health officials should address needs of people with blood disorders

Public health officials should address needs of people with blood disorders

Increasing TR2/TR4 expression can lead to higher fetal hemoglobin levels in sickle cell patients

Increasing TR2/TR4 expression can lead to higher fetal hemoglobin levels in sickle cell patients

Alexion third quarter total revenues increase to $204.0 million

Alexion third quarter total revenues increase to $204.0 million

ApoPharma receives FDA approval for Ferriprox to treat transfusional iron overload

ApoPharma receives FDA approval for Ferriprox to treat transfusional iron overload

Potential new protein target for sickle cell disease

Potential new protein target for sickle cell disease

Study identifies gene mutation responsible for higher frequency of Italian CDA II

Study identifies gene mutation responsible for higher frequency of Italian CDA II

Researchers use patient's own stem cells to correct genetic alteration that causes SCD

Researchers use patient's own stem cells to correct genetic alteration that causes SCD

Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome

Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome